Methylprednisolone Pulse Treatment of Graves' Ophthalmopathy Is Not Associated with Secondary Adrenocortical Insufficiency

Publisher： Karger

E-ISSN： 2235-0802|4|4|222-225

ISSN： 2235-0640

Source： European Thyroid Journal, Vol.4, Iss.4, 2015-0, pp. : 222-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjuvant Treatment of Graves' Disease with Diclofenac: Safety, Effects on Ophthalmopathy and Antibody Concentrations

By  

European Thyroid Journal, Vol. 5, Iss. 1, 2016-02 ,pp. : 50-56

Karger

Access to resources Recommend Favorite

Platelet-Derived Growth Factor: A Key Factor in the Pathogenesis of Graves' Ophthalmopathy and Potential Target for Treatment

By  

European Thyroid Journal, Vol. 3, Iss. 4, 2014-12 ,pp. : 217-226

Karger

Access to resources Recommend Favorite

Differential Involvement of Orbital Fat and Extraocular Muscles in Graves' Ophthalmopathy

By  

European Thyroid Journal, Vol. 2, Iss. 1, 2013-02 ,pp. : 14-21

Karger

Access to resources Recommend Favorite

Adrenocortical Cancer Treatment

By  

Hormone Research in Paediatrics, Vol. 71, Iss. 1, 2009-01 ,pp. : 99-104

Karger

Access to resources Recommend Favorite

Oxidative Stress, Nuclear Factor-κB Pathway and Current Smoking in Graves' Ophthalmopathy

By  

European Thyroid Journal, Vol. 2, Iss. 1, 2013-02 ,pp. : 69-70

Karger

Access to resources Recommend Favorite